Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors

Inclusion Criteria: * One to 2 painful vertebrae (T1-L5) with evidence of osteolytic metastatic lesion with known primary histology with pathologic fracture(s) at index vertebra by MRI * Pain score ≥ 4 on the numerical rating pain scale * Life expectancy of ≥ 6 months Exclusion Criteria: * Primary tumors of the bone at index vertebra * Benign tumors of the bone at index vertebra * Osteoblastic tumors at index vertebra * Index vertebra with more than one (1) pedicle involved * Epidural extension of tumor within 5 mm of the spinal cord or without sufficient room for thermal protective maneuvers * Spinal cord compression or canal compromise requiring decompression * Radiation therapy is planned to be started on the index vertebra within 4 weeks post procedure * Radiation therapy was performed on the index vertebra within 2 months before enrollment * Major surgery of the spine was performed within 3 months before enrollment * Index vertebra(e) had previous spine surgery including vertebroplasty or kyphoplasty * Additional non-kyphoplasty/vertebroplasty surgical treatment is required for the index vertebra